Brief: Kang Stem Biotech receives patent

Kang Stem Biotech

03/11/2016 03:09

Nov 3 (Reuters) - Kang Stem Biotech Co Ltd  217730.KQ  : 
 
    * Says it received Japan patent on Nov. 2, for isolating 
method for umbilical cord blood-derived pluripotent stem cells 
expressing ZNF281 
    * Says patent owner is SNU R&DB Foundation and exclusive 
license holder is Kang Stem Biotech Co Ltd  
     
     
    Source text in Korean: https://goo.gl/6WfEu2 
    Further company coverage:  217730.KQ  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))